Literature DB >> 14611745

Growth factors and the development of diabetic nephropathy.

Gunter Wolf1.   

Abstract

Growth factors play an important role in the development of functional and structural changes associated with diabetic nephropathy. Although it has been known for years that these factors are important for early renal hypertrophy and subsequent development of glomerulosclerosis and tubulointerstitial fibrosis, the exact molecular mechanism of many of these factors has only recently been more elucidated. Furthermore, growth factors also link the metabolic theory of diabetic complications with renal hemodynamic changes in diabetic nephropathy because some growth factors could directly influence glomerular hemodynamics and tubular transport in diabetic nephropathy. The high glucose environment with stimulated cellular uptake of glucose and accelerated nonenzymatic reactions resulting in Amadori-modified proteins and the later-developing advanced glycation end products are the main stimulators for intrarenal induction of growth factors. Intracellular generation of reactive species is an important signal intermediate in these stimulated expressions of growth factors. Taking into consideration the pivotal role of growth factors in the development of diabetic nephropathy, a therapeutic strategy to antagonize growth factor effects appears to be straightforward. However, the pleiotropic function of many of these factors and their physiologic role in normal renal homeostasis may make this approach difficult.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14611745     DOI: 10.1007/s11892-003-0012-2

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   5.430


  50 in total

1.  Biochemistry and molecular cell biology of diabetic complications.

Authors:  M Brownlee
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

2.  BMP7 antagonizes TGF-beta -dependent fibrogenesis in mesangial cells.

Authors:  Shinong Wang; Raimund Hirschberg
Journal:  Am J Physiol Renal Physiol       Date:  2003-05

3.  Hypoxia and interleukin-1beta stimulate vascular endothelial growth factor production in human proximal tubular cells.

Authors:  B El Awad; B Kreft; E M Wolber; T Hellwig-Bürgel; E Metzen; J Fandrey; W Jelkmann
Journal:  Kidney Int       Date:  2000-07       Impact factor: 10.612

Review 4.  Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease.

Authors:  A Flyvbjerg
Journal:  Diabetologia       Date:  2000-10       Impact factor: 10.122

5.  In vivo and in vitro evidence for increased expression of HGF receptor in kidney of diabetic rat.

Authors:  Y Liu; E M Tolbert; A M Sun; L D Dworkin
Journal:  Am J Physiol       Date:  1996-12

6.  TGF-beta-induced Ca(2+) influx involves the type III IP(3) receptor and regulates actin cytoskeleton.

Authors:  Tracy A McGowan; Muniswamy Madesh; Yanqing Zhu; Lewei Wang; Mark Russo; Leo Deelman; Rob Henning; Suresh Joseph; Gyorgy Hajnoczky; Kumar Sharma
Journal:  Am J Physiol Renal Physiol       Date:  2002-05

7.  Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells.

Authors:  M Murphy; C Godson; S Cannon; S Kato; H S Mackenzie; F Martin; H R Brady
Journal:  J Biol Chem       Date:  1999-02-26       Impact factor: 5.157

8.  Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes.

Authors:  M Carmen Iglesias-de la Cruz; Fuad N Ziyadeh; Motohide Isono; Martine Kouahou; Dong Cheol Han; Raghu Kalluri; Peter Mundel; Sheldon Chen
Journal:  Kidney Int       Date:  2002-09       Impact factor: 10.612

9.  The effect of growth hormone on the development of diabetic kidney disease in rats.

Authors:  Daniel Landau; Eytan Israel; Inessa Rivkis; Leonid Kachko; Bieke F Schrijvers; Allan Flyvbjerg; Moshe Phillip; Yael Segev
Journal:  Nephrol Dial Transplant       Date:  2003-04       Impact factor: 5.992

10.  IGF-I induces vascular endothelial growth factor in human mesangial cells via a Src-dependent mechanism.

Authors:  Gabriella Gruden; Shawanna Araf; Silvia Zonca; Davina Burt; Stephen Thomas; Luigi Gnudi; Giancarlo Viberti
Journal:  Kidney Int       Date:  2003-04       Impact factor: 10.612

View more
  11 in total

1.  Thrombospondin 1 and Its Diverse Roles as a Regulator of Extracellular Matrix in Fibrotic Disease.

Authors:  Joanne E Murphy-Ullrich
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

2.  Blockade of TSP1-dependent TGF-β activity reduces renal injury and proteinuria in a murine model of diabetic nephropathy.

Authors:  Ailing Lu; Mi Miao; Trenton R Schoeb; Anupam Agarwal; Joanne E Murphy-Ullrich
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

3.  The angiotensin receptor blocker losartan reduces coronary arteriole remodeling in type 2 diabetic mice.

Authors:  Kathryn E Husarek; Paige S Katz; Aaron J Trask; Maarten L Galantowicz; Mary J Cismowski; Pamela A Lucchesi
Journal:  Vascul Pharmacol       Date:  2015-06-30       Impact factor: 5.773

4.  Acetylshikonin from Zicao ameliorates renal dysfunction and fibrosis in diabetic mice by inhibiting TGF-β1/Smad pathway.

Authors:  Zezhao Li; Zhen Hong; Zhiqing Peng; Yongcai Zhao; Rusheng Shao
Journal:  Hum Cell       Date:  2018-03-17       Impact factor: 4.174

5.  Overproduction of phosphoprotein enriched in diabetes (PED) induces mesangial expansion and upregulates protein kinase C-beta activity and TGF-beta1 expression.

Authors:  F Oriente; S Iovino; A Cassese; C Romano; C Miele; G Troncone; M Balletta; A Perfetti; G Santulli; G Iaccarino; R Valentino; F Beguinot; P Formisano
Journal:  Diabetologia       Date:  2009-09-30       Impact factor: 10.122

6.  17beta-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-beta protein expression and signaling.

Authors:  Alexis Dixon; Christine Maric
Journal:  Am J Physiol Renal Physiol       Date:  2007-08-08

7.  Advanced glycated end-products affect HIF-transcriptional activity in renal cells.

Authors:  Tzvetanka Bondeva; Juliane Heinzig; Carola Ruhe; Gunter Wolf
Journal:  Mol Endocrinol       Date:  2013-09-12

Review 8.  Spinal Muscular Atrophy Modeling and Treatment Advances by Induced Pluripotent Stem Cells Studies.

Authors:  Raffaella Adami; Daniele Bottai
Journal:  Stem Cell Rev Rep       Date:  2019-12       Impact factor: 5.739

9.  Blockade of KCa3.1 ameliorates renal fibrosis through the TGF-β1/Smad pathway in diabetic mice.

Authors:  Chunling Huang; Sylvie Shen; Qing Ma; Jason Chen; Anthony Gill; Carol A Pollock; Xin-Ming Chen
Journal:  Diabetes       Date:  2013-05-08       Impact factor: 9.461

10.  KCa3.1 mediates activation of fibroblasts in diabetic renal interstitial fibrosis.

Authors:  Chunling Huang; Sylvie Shen; Qing Ma; Anthony Gill; Carol A Pollock; Xin-Ming Chen
Journal:  Nephrol Dial Transplant       Date:  2013-10-28       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.